Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$4.17 - $5.74 $91,594 - $126,079
-21,965 Closed
0 $0
Q1 2021

May 07, 2021

SELL
$5.28 - $9.64 $1,430 - $2,612
-271 Reduced 1.22%
21,965 $116,000
Q4 2020

Feb 12, 2021

BUY
$5.75 - $7.13 $287 - $356
50 Added 0.23%
22,236 $145,000
Q3 2020

Nov 04, 2020

SELL
$4.9 - $7.12 $2,366 - $3,438
-483 Reduced 2.13%
22,186 $136,000
Q2 2020

Aug 12, 2020

BUY
$6.43 - $9.86 $1,466 - $2,248
228 Added 1.02%
22,669 $165,000
Q1 2020

May 04, 2020

SELL
$6.36 - $10.05 $7,065 - $11,165
-1,111 Reduced 4.72%
22,441 $156,000
Q4 2019

Feb 05, 2020

SELL
$8.49 - $12.81 $857 - $1,293
-101 Reduced 0.43%
23,552 $208,000
Q3 2019

Nov 08, 2019

SELL
$5.58 - $14.47 $1,936 - $5,021
-347 Reduced 1.45%
23,653 $265,000
Q2 2019

Aug 13, 2019

BUY
$5.22 - $9.08 $5,220 - $9,080
1,000 Added 4.35%
24,000 $145,000
Q1 2019

May 06, 2019

SELL
$5.35 - $9.82 $3,086 - $5,666
-577 Reduced 2.45%
23,000 $181,000
Q4 2018

Feb 13, 2019

BUY
$3.43 - $6.19 $655 - $1,182
191 Added 0.82%
23,577 $117,000
Q3 2018

Nov 09, 2018

BUY
$4.75 - $14.5 $4,056 - $12,383
854 Added 3.79%
23,386 $111,000
Q2 2018

Aug 08, 2018

BUY
$13.3 - $17.45 $57,549 - $75,506
4,327 Added 23.77%
22,532 $306,000
Q1 2018

May 07, 2018

SELL
$14.7 - $24.95 $68,193 - $115,743
-4,639 Reduced 20.31%
18,205 $292,000
Q4 2017

Feb 09, 2018

BUY
$19.9 - $29.25 $6,964 - $10,237
350 Added 1.56%
22,844 $530,000
Q3 2017

Nov 09, 2017

BUY
$15.1 - $19.25 $339,659 - $433,009
22,494
22,494 $415,000

Others Institutions Holding LCI

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About LANNETT CO INC


  • Ticker LCI
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 42,960,000
  • Market Cap $1.29M
  • Description
  • Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...
More about LCI
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.